pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
pharmadog news

Browse

2,267 stories matching this filter · ← front page

★ save view↓export CSV
rangeto
sort
recentoldestsourcealpha
source
STAT1171Endpoints885BioPharma Dive340BioSpace304Fierce Biotech287onclive165raps104globenewswire health73
therapy area
allOncology7528Rare Disease1860Cardiology1714Immunology1473Hematology1317Vaccines1195Pulmonology
  • FDA greenlights Colorado's plan to import prescription drugs from Canada to lower costs
    The FDA announced Monday that Colorado will be allowed to bring in certain prescription medicines from Canada, aiming to reduce drug prices for state residents. This decision makes Colorado the se…
    STAT · 2mo agoApprovalPositive↗ source
  • FDA greenlights Colorado plan to import prescription drugs from Canada to lower prices
    FDA announced Monday that Colorado will be allowed to import certain prescription medicines from Canada, making it the second state to receive such authorization after Florida. The move is intende…
    STAT · 2mo agoApprovalPositive↗ source
← prev
page 61 of 91
next →
fda recalls67
fda medwatch60
fda press38
1145
Psychiatry & CNS866
Ophthalmology494
Pain478
Endocrinology & Metabolism468
Infectious Disease444
  • European trial registry shows under half of studies missing timely results, analysis says
    A new analysis of a major European clinical trial database found that fewer than half of the studies reported results within the legally required timeframe, and only 42% provided complete data. Th…
    STAT · 2mo agoRegulatoryNegative↗ source
  • Covid vaccine linked to 24% drop in overall cardiac events, study of 1 million veterans shows
    A new analysis of more than one million U.S. veterans indicates that receiving a Covid‑19 vaccine is associated with a substantial reduction in heart‑related problems. Researchers observed a roughl…
    STAT · 2mo agoPositive readoutPositive↗ source
  • Lilly reports early positive results for new JAK2 inhibitor in hard-to-treat myelofibrosis
    Lilly has incorporated a JAK2‑targeting drug originally discovered by Ajax Therapeutics after its recent acquisition. The experimental pill is intended for patients with myelofibrosis, a difficult‑…
    BioPharma Dive · 2mo agoPositive readoutPositive↗ source
  • Sanofi’s Tzield approved amid review dispute as Bicillin shortage hampers syphilis treatment
    An Arizona woman pregnant with syphilis could not receive timely treatment because of a worsening shortage of Bicillin, the injectable penicillin made by Pfizer. The shortage has raised concerns ab…
    STAT · 2mo agoRegulatoryNeutral↗ source
  • US sees 800% rise in congenital syphilis births amid penicillin shortage, officials warn of preventable "never event"
    The article notes a dramatic surge in congenital syphilis cases in the United States, with births affected rising about 800% between 2012 and 2024. This increase is described as a "never event" bec…
    STAT · 2mo agoNegative↗ source
  • Celiac disease faces new therapeutic possibilities as companies target underlying inflammation
    Celiac disease affects roughly one in every hundred people worldwide, imposing a daily burden that goes far beyond dietary restrictions. Currently, patients have no approved medicines and must rel…
    BioPharma Dive · 2mo agoPositive↗ source
  • Pfizer fails to provide emergency penicillin donations as Trump administration seeks policy change to curb drugmaker price avoidance
    Pfizer has not complied with a request from state health agencies to donate emergency penicillin, a measure intended to act as a backstop against congenital syphilis. The shortfall underscores ong…
    STAT · 2mo agoRegulatoryNegative↗ source
  • Medicaid fraud crackdown threatens home care for disabled, risking loss of essential services
    States are adopting a Medicaid fraud enforcement strategy modeled on the Trump administration, tightening regulations and cutting funding that many disability advocates say will strain the home‑car…
    STAT · 2mo agoRegulatoryNegative↗ source
  • Strategic steps for moving sterile injectables from lab to clinical trials
    The article, sponsored by Vetter, discusses how drug owners of sterile injectable candidates face a key question when a molecule is ready for first‑in‑human studies: how fast can a clinical batch b…
    BioPharma Dive · 2mo agoPositive↗ source
  • South Asian American families often keep autism diagnoses hidden, delaying care
    Child and adolescent psychiatrist Ritu Goel points out that the CDC now estimates autism affects about one in 31 U.S. children, a rise from earlier figures. She observes that many South Asian Ameri…
    STAT · 2mo agoNegative↗ source
  • Pediatrician urges rigorous trials for AI tools used with children
    Dr. Dua Hassan, a pediatrician at Boston Children’s Hospital, writes an opinion piece about the growing use of artificial-intelligence applications in child care. She describes a typical office vi…
    STAT · 2mo agoNeutral↗ source
  • California law bans four harmful food additives, part of legislator Jesse Gabriel's push against ultra-processed foods
    California Assemblymember Jesse Gabriel has become a prominent figure in state food policy, championing measures aimed at reducing the health risks of ultra-processed foods. In 2023 he introduced…
    STAT · 2mo agoRegulatoryPositive↗ source
  • FDA approves Sanofi's teplizumab for children with stage 3 type 1 diabetes
    The FDA announced approval of teplizumab, a Sanofi developed therapy, for children aged 8 and older who have stage 3 type 1 diabetes. The decision came through the agency’s accelerated review path…
    STAT · 2mo agoApprovalPositive↗ source
  • WHO chief warns of worsening Ebola outbreak in DRC and Uganda after on-site visit
    The World Health Organization's director‑general said he is "really worried" after returning from a second trip to the Ebola‑affected regions of the Democratic Republic of the Congo and Uganda. He…
    STAT · 2mo agoNegative↗ source
  • 73-year-old woman begins medical residency, says she's all in
    In a recent First Opinion podcast, Dawn Zuidgeest-Craft, who is nearly 73, shared her decision to start a medical residency after completing medical school in her early seventies. The interview was…
    STAT · 2mo agoPositive↗ source
  • Prometheus secures $12 billion to develop artificial general engineers as biotech deals surge
    Prometheus announced a $12 billion capital raise aimed at building what it calls “artificial general engineers,” a new class of AI tools for biopharma research and development. Nonprofit Blood Can…
    STAT · 2mo agoDealPositive↗ source
  • Trump administration proposes rule to close Medicare drug price-negotiation loophole
    The White House announced a proposal to tighten a policy that stops drugmakers from sidestepping Medicare price negotiations by adding new active ingredients to existing products. The change would…
    STAT · 2mo agoRegulatoryNeutral↗ source
  • Engaging Religious Leaders Key to Containing Ebola in DRC and Uganda
    An opinion piece by Olivia Wilkinson and Katherine Marshall stresses that Ebola spreads through caring acts such as tending the sick and handling burials, and that mistrust and misinformation often…
    STAT · 2mo agoPositive↗ source
  • Rapport Therapeutics says it is ready to launch its seizure drug independently
    In a recent interview, CEO Abe Ceesay explained that Rapport Therapeutics has assembled an investor syndicate and feels fully prepared to bring its seizure drug to market on its own. Founded in 20…
    BioPharma Dive · 2mo agoDealPositive↗ source
  • Veteran researcher warns new OMB grant rule could politicize U.S. science
    David J. Skorton, president of the Association of American Medical Colleges, writes that after four decades in research he has never seen a threat to science like the new grantmaking rule being con…
    STAT · 2mo agoRegulatoryNegative↗ source
  • Hospital finance leaders call for ending billing friction that drives high costs
    At the Healthcare Financial Management Association’s annual meeting in Maryland, hospital finance executives gathered to discuss the persistent problem of affordability in health care. While the hi…
    STAT · 2mo agoNegative↗ source
  • AstronauTx appoints Michelle Mellion as new chief medical officer
    STAT+ columnist Ed Silverman reports on the latest personnel moves in the pharmaceutical sector, a regular feature that tracks hires, promotions and departures. The most recent addition is Michell…
    STAT · 2mo agoPositive↗ source
  • ADA apologizes after expelling five experts for distributing editorial at diabetes conference
    At the American Diabetes Association's annual meeting in New Orleans, five diabetes researchers were expelled and warned they could be arrested after distributing paper copies of an editorial. The…
    STAT · 2mo agoNegative↗ source